1	Tumor	Tumor	B-NP	NN	O	2	NMOD	0
2	angiogenesis	angiogenesis	I-NP	NN	O	3	SUB	3	angiogenesis
3	modulates	modulate	B-VP	VBZ	O	0	ROOT	16	modulates
4	leukocyte-vessel	leukocyte-vessel	B-NP	JJ	O	6	NMOD	0
5	wall	wall	I-NP	NN	O	6	NMOD	0
6	interactions	interaction	I-NP	NNS	O	3	OBJ	15	interactions
7	in	in	B-ADVP	FW	O	3	VMOD	0
8	vivo	vivo	I-ADVP	FW	O	7	AMOD	0
9	by	by	B-PP	IN	O	3	VMOD	0
10	reducing	reduce	B-VP	VBG	O	9	PMOD	18	reducing
11	endothelial	endothelial	B-NP	JJ	B-protein	14	NMOD	0
12	adhesion	adhesion	I-NP	NN	I-protein	14	NMOD	0
13	molecule	molecule	I-NP	NN	I-protein	14	NMOD	0
14	expression	expression	I-NP	NN	O	10	OBJ	9	expression
15	.	.	O	.	O	3	P	0

1	The	The	B-NP	DT	O	2	NMOD	0
2	expression	expression	I-NP	NN	O	16	SUB	9	expression
3	of	of	B-PP	IN	O	2	NMOD	0
4	endothelial	endothelial	B-NP	JJ	B-protein	10	NMOD	0
5	cell	cell	I-NP	NN	I-protein	10	NMOD	0
6	(	(	O	(	I-protein	10	NMOD	0
7	EC	EC	B-NP	NN	I-protein	10	NMOD	0
8	)	)	O	)	I-protein	10	NMOD	0
9	adhesion	adhesion	B-NP	NN	I-protein	10	NMOD	0
10	molecules	molecule	I-NP	NNS	I-protein	3	PMOD	0
11	involved	involve	B-VP	VBN	O	10	NMOD	16	involved
12	in	in	B-PP	IN	O	11	VMOD	0
13	leukocyte-vessel	leukocyte-vessel	B-NP	JJ	O	15	NMOD	0
14	wall	wall	I-NP	NN	O	15	NMOD	0
15	interactions	interaction	I-NP	NNS	O	12	PMOD	15	interactions
16	is	be	B-VP	VBZ	O	0	ROOT	0
17	suppressed	suppress	I-VP	VBN	O	16	VC	0
18	in	in	B-PP	IN	O	17	VMOD	0
19	malignancies	malignancy	B-NP	NNS	O	18	PMOD	0
20	.	.	O	.	O	16	P	0

1	In	In	B-PP	IN	O	7	VMOD	0
2	the	the	B-NP	DT	O	4	NMOD	0
3	present	present	I-NP	JJ	O	4	NMOD	0
4	study	study	I-NP	NN	O	1	PMOD	0
5	,	,	O	,	O	7	P	0
6	we	we	B-NP	PRP	O	7	SUB	0
7	investigated	investigate	B-VP	VBD	O	0	ROOT	0
8	in	in	B-ADVP	FW	O	7	VMOD	0
9	vivo	vivo	I-ADVP	FW	O	8	AMOD	0
10	the	the	B-NP	DT	O	11	NMOD	0
11	regulation	regulation	I-NP	NN	O	7	OBJ	16	regulation
12	of	of	B-PP	IN	O	11	NMOD	0
13	leukocyte-vessel	leukocyte-vessel	B-NP	JJ	O	15	NMOD	0
14	wall	wall	I-NP	NN	O	15	NMOD	0
15	interactions	interaction	I-NP	NNS	O	12	PMOD	15	interactions
16	by	by	B-PP	IN	O	11	NMOD	0
17	the	the	B-NP	DT	O	18	NMOD	0
18	presence	presence	I-NP	NN	O	16	PMOD	0
19	of	of	B-PP	IN	O	18	NMOD	0
20	a	a	B-NP	DT	O	21	NMOD	0
21	tumor	tumor	I-NP	NN	O	19	PMOD	0
22	.	.	O	.	O	7	P	0

1	By	By	B-PP	IN	O	14	VMOD	0
2	means	mean	B-NP	NNS	O	1	PMOD	0
3	of	of	B-PP	IN	O	2	NMOD	0
4	intravital	intravital	B-NP	JJ	O	5	NMOD	0
5	microscopy	microscopy	I-NP	NN	O	13	NMOD	0
6	,	,	O	,	O	13	P	0
7	tumor	tumor	B-NP	NN	B-protein	9	AMOD	0
8	necrosis	necrosis	I-NP	NN	I-protein	9	AMOD	0
9	factor	factor	I-NP	NN	I-protein	13	NMOD	0
10	alpha-stimulated	alpha-stimulated	I-NP	JJ	O	13	NMOD	17	stimulated
11	leukocyte-vessel	leukocyte-vessel	I-NP	JJ	O	13	NMOD	0
12	wall	wall	I-NP	NN	O	13	NMOD	0
13	interactions	interaction	I-NP	NNS	O	3	PMOD	15	interactions
14	were	be	B-VP	VBD	O	0	ROOT	0
15	studied	study	I-VP	VBN	O	14	VC	0
16	in	in	B-PP	IN	O	15	VMOD	0
17	ear	ear	B-NP	JJ	O	19	NMOD	0
18	skin	skin	I-NP	NN	O	19	NMOD	0
19	microvessels	microvessel	I-NP	NNS	O	16	PMOD	0
20	of	of	B-PP	IN	O	19	NMOD	0
21	nude	nude	B-NP	JJ	O	22	NMOD	0
22	mice	mouse	I-NP	NNS	O	20	PMOD	0
23	bearing	bear	B-VP	VBG	O	22	NMOD	0
24	small	small	B-NP	JJ	O	28	NMOD	0
25	human	human	I-NP	JJ	O	28	NMOD	0
26	LS174T	LS174T	I-NP	NN	O	28	NMOD	0
27	colon	colon	I-NP	NN	O	28	NMOD	0
28	carcinomas	carcinoma	I-NP	NNS	O	23	OBJ	0
29	and	and	B-PP	CC	O	16	PMOD	0
30	in	in	B-PP	IN	O	16	PMOD	0
31	C57Bl/6	C57Bl/6	B-NP	NN	O	32	NMOD	0
32	mice	mouse	I-NP	NNS	O	30	PMOD	0
33	bearing	bear	B-VP	VBG	O	32	NMOD	0
34	murine	murine	B-NP	JJ	O	36	NMOD	0
35	B16F10	B16F10	I-NP	NN	O	36	NMOD	0
36	melanomas	melanoma	I-NP	NNS	O	33	OBJ	0
37	.	.	O	.	O	14	P	0

1	Leukocyte-vessel	Leukocyte-vessel	B-NP	JJ	O	3	NMOD	0
2	wall	wall	I-NP	NN	O	3	NMOD	0
3	interactions	interaction	I-NP	NNS	O	4	SUB	15	interactions
4	were	be	B-VP	VBD	O	0	ROOT	0
5	studied	study	I-VP	VBN	O	4	VC	0
6	both	both	O	CC	O	5	VMOD	0
7	within	within	B-PP	IN	O	6	PMOD	0
8	and	and	I-PP	CC	O	6	PMOD	0
9	outside	outside	I-PP	IN	O	6	DEP	0
10	small	small	B-NP	JJ	O	11	NMOD	0
11	tumors	tumor	I-NP	NNS	O	9	PMOD	0
12	growing	grow	B-VP	VBG	O	11	NMOD	4	growing
13	in	in	B-PP	IN	O	12	VMOD	0
14	the	the	B-NP	DT	O	15	NMOD	0
15	ear	ear	I-NP	NN	O	13	PMOD	0
16	,	,	O	,	O	4	P	0
17	and	and	O	CC	O	16	VMOD	0
18	in	in	B-PP	IN	O	17	PRD	0
19	ear	ear	B-NP	JJ	O	20	NMOD	0
20	microvessels	microvessel	I-NP	NNS	O	18	PMOD	0
21	of	of	B-PP	IN	O	20	NMOD	0
22	mice	mouse	B-NP	NNS	O	21	PMOD	0
23	with	with	B-PP	IN	O	18	PMOD	0
24	a	a	B-NP	DT	O	26	NMOD	0
25	large	large	I-NP	JJ	O	26	NMOD	0
26	tumor	tumor	I-NP	NN	O	23	PMOD	0
27	growing	grow	B-VP	VBG	O	26	NMOD	4	growing
28	on	on	B-PP	IN	O	27	VMOD	0
29	their	their	B-NP	PRP$	O	30	NMOD	0
30	flank	flank	I-NP	NN	O	28	PMOD	0
31	.	.	O	.	O	4	P	0

1	Tumor-free	Tumor-free	B-NP	JJ	O	2	NMOD	0
2	mice	mouse	I-NP	NNS	O	3	SUB	0
3	were	be	B-VP	VBD	O	0	ROOT	0
4	used	use	I-VP	VBN	O	3	VC	0
5	as	as	B-PP	IN	O	4	VMOD	0
6	controls	control	B-NP	NNS	O	5	PMOD	0
7	.	.	O	.	O	3	P	0

1	Compared	Compare	B-PP	VBN	O	19	VMOD	0
2	with	with	B-PP	IN	O	1	VMOD	0
3	values	value	B-NP	NNS	O	2	PMOD	0
4	measured	measure	B-VP	VBN	O	3	NMOD	0
5	at	at	B-PP	IN	O	4	VMOD	0
6	the	the	B-NP	DT	O	7	NMOD	0
7	edge	edge	I-NP	NN	O	5	PMOD	0
8	of	of	B-PP	IN	O	7	NMOD	0
9	the	the	B-NP	DT	O	10	NMOD	0
10	ear	ear	I-NP	NN	O	8	PMOD	0
11	and	and	B-PP	CC	O	5	PMOD	0
12	in	in	B-PP	IN	O	5	PMOD	0
13	the	the	B-NP	DT	O	15	NMOD	0
14	contralateral	contralateral	I-NP	JJ	O	15	NMOD	0
15	ear	ear	I-NP	NN	O	12	PMOD	0
16	,	,	O	,	O	19	P	0
17	leukocyte	leukocyte	B-NP	NN	O	18	NMOD	0
18	adhesion	adhesion	I-NP	NN	O	19	SUB	15	adhesion
19	was	be	B-VP	VBD	O	0	ROOT	0
20	found	find	I-VP	VBN	O	19	VC	0
21	to	to	I-VP	TO	O	22	VMOD	0
22	be	be	I-VP	VB	O	20	VMOD	0
23	diminished	diminish	I-VP	VBN	O	22	VC	18	diminished
24	significantly	significantly	B-ADVP	RB	O	23	VMOD	0
25	in	in	B-PP	IN	O	23	VMOD	0
26	vessels	vessel	B-NP	NNS	O	25	PMOD	0
27	inside	inside	B-PP	IN	O	23	VMOD	0
28	the	the	B-NP	DT	O	30	NMOD	0
29	ear	ear	I-NP	JJ	O	30	NMOD	0
30	tumor	tumor	I-NP	NN	O	27	PMOD	0
31	in	in	B-PP	IN	O	30	NMOD	0
32	both	both	B-NP	DT	O	34	NMOD	0
33	mouse	mouse	I-NP	NN	O	34	NMOD	0
34	models	model	I-NP	NNS	O	31	PMOD	0
35	.	.	O	.	O	19	P	0

1	This	This	B-NP	DT	O	2	NMOD	0
2	reduction	reduction	I-NP	NN	O	3	SUB	18	reduction
3	disappeared	disappear	B-VP	VBD	O	0	ROOT	0
4	with	with	B-PP	IN	O	3	VMOD	0
5	increasing	increase	B-NP	VBG	O	6	NMOD	0
6	distance	distance	I-NP	NN	O	4	PMOD	0
7	from	from	B-PP	IN	O	6	NMOD	0
8	the	the	B-NP	DT	O	9	NMOD	0
9	tumor	tumor	I-NP	NN	O	7	PMOD	0
10	.	.	O	.	O	3	P	0

1	Surprisingly	Surprisingly	B-ADVP	RB	O	18	VMOD	0
2	,	,	O	,	O	18	P	0
3	the	the	B-NP	DT	O	4	NMOD	0
4	level	level	I-NP	NN	O	18	SUB	0
5	of	of	B-PP	IN	O	4	NMOD	0
6	leukocyte	leukocyte	B-NP	NN	O	7	NMOD	0
7	adhesion	adhesion	I-NP	NN	O	5	PMOD	15	adhesion
8	in	in	B-PP	IN	O	4	NMOD	0
9	ear	ear	B-NP	JJ	O	10	NMOD	0
10	venules	venule	I-NP	NNS	O	8	PMOD	0
11	of	of	B-PP	IN	O	10	NMOD	0
12	mice	mouse	B-NP	NNS	O	11	PMOD	0
13	with	with	B-PP	IN	O	4	NMOD	0
14	a	a	B-NP	DT	O	17	NMOD	0
15	large	large	I-NP	JJ	O	17	NMOD	0
16	flank	flank	I-NP	JJ	O	17	NMOD	0
17	tumor	tumor	I-NP	NN	O	13	PMOD	0
18	was	be	B-VP	VBD	O	0	ROOT	0
19	also	also	I-VP	RB	O	18	VMOD	0
20	reduced	reduce	I-VP	VBN	O	18	VC	18	reduced
21	significantly	significantly	B-ADVP	RB	O	20	VMOD	0
22	.	.	O	.	O	18	P	0

1	Leukocyte	Leukocyte	B-NP	NN	O	2	NMOD	0
2	rolling	rolling	I-NP	NN	O	11	SUB	0
3	,	,	O	,	O	11	P	0
4	i.e.	i.e.	B-NP	FW	O	11	VMOD	0
5	,	,	O	,	O	11	P	0
6	the	the	B-NP	DT	O	11	SUB	0
7	step	step	I-NP	NN	O	11	VMOD	0
8	preceding	precede	B-VP	VBG	O	7	NMOD	0
9	adhesion	adhesion	B-NP	NN	O	8	OBJ	0
10	,	,	O	,	O	11	P	0
11	was	be	B-VP	VBD	O	0	ROOT	0
12	not	not	I-VP	RB	O	11	VMOD	0
13	influenced	influence	I-VP	VBN	O	11	VC	0
14	by	by	B-PP	IN	O	13	VMOD	0
15	the	the	B-NP	DT	O	16	NMOD	0
16	presence	presence	I-NP	NN	O	14	PMOD	0
17	of	of	B-PP	IN	O	16	NMOD	0
18	a	a	B-NP	DT	O	19	NMOD	0
19	tumor	tumor	I-NP	NN	O	17	PMOD	0
20	in	in	B-PP	IN	O	16	NMOD	0
21	nude	nude	B-NP	JJ	O	22	NMOD	0
22	mice	mouse	I-NP	NNS	O	20	PMOD	0
23	,	,	O	,	O	11	P	0
24	but	but	O	CC	O	11	VMOD	0
25	was	be	B-VP	VBD	O	11	VMOD	0
26	down-regulated	down-regulate	I-VP	VBN	O	25	VC	0
27	in	in	B-PP	IN	O	26	VMOD	0
28	immune-competent	immune-competent	B-NP	JJ	O	30	NMOD	0
29	C57Bl/6	C57Bl/6	I-NP	NN	O	30	NMOD	0
30	mice	mouse	I-NP	NNS	O	27	PMOD	0
31	.	.	O	.	O	11	P	0

1	Treatment	Treatment	B-NP	NN	O	17	SUB	19	Treatment
2	of	of	B-PP	IN	O	1	NMOD	0
3	mice	mouse	B-NP	NNS	O	2	PMOD	0
4	bearing	bear	B-VP	VBG	O	3	NMOD	0
5	a	a	B-NP	DT	O	8	NMOD	0
6	small	small	I-NP	JJ	O	8	NMOD	0
7	ear	ear	I-NP	JJ	O	8	NMOD	0
8	tumor	tumor	I-NP	NN	O	4	OBJ	0
9	with	with	B-PP	IN	O	4	VMOD	0
10	a	a	B-NP	DT	O	16	NMOD	0
11	humanized	humanized	I-NP	JJ	B-protein	16	NMOD	0
12	antivascular	antivascular	I-NP	JJ	I-protein	16	NMOD	0
13	endothelial	endothelial	I-NP	JJ	I-protein	16	NMOD	0
14	growth	growth	I-NP	NN	I-protein	16	NMOD	0
15	factor	factor	I-NP	NN	I-protein	16	NMOD	0
16	antibody	antibody	I-NP	NN	I-protein	9	PMOD	0
17	prevented	prevent	B-VP	VBD	O	0	ROOT	18	prevented
18	the	the	B-NP	DT	O	19	NMOD	0
19	down-regulation	down-regulation	I-NP	NN	O	17	OBJ	18	down-regulation
20	of	of	B-PP	IN	O	19	NMOD	0
21	leukocyte-vessel	leukocyte-vessel	B-NP	JJ	O	23	NMOD	0
22	wall	wall	I-NP	NN	O	23	NMOD	0
23	interactions	interaction	I-NP	NNS	O	20	PMOD	15	interactions
24	inside	inside	B-PP	IN	O	19	NMOD	0
25	the	the	B-NP	DT	O	27	NMOD	0
26	tumor	tumor	I-NP	NN	O	27	NMOD	0
27	vessels	vessel	I-NP	NNS	O	24	PMOD	0
28	compared	compare	B-PP	VBN	O	17	VMOD	0
29	with	with	B-PP	IN	O	28	PMOD	0
30	the	the	B-NP	DT	O	32	NMOD	0
31	nontreated	nontreated	I-NP	JJ	O	32	NMOD	19	nontreated
32	group	group	I-NP	NN	O	29	PMOD	0
33	.	.	O	.	O	17	P	0

1	Fluorescence-activated	Fluorescence-activated	B-NP	JJ	O	4	NMOD	17	activated
2	cell	cell	I-NP	NN	O	4	NMOD	0
3	sorter	sorter	I-NP	NN	O	4	NMOD	0
4	analysis	analysis	I-NP	NN	O	5	SUB	0
5	showed	show	B-VP	VBD	O	0	ROOT	0
6	that	that	B-SBAR	IN	O	5	VMOD	0
7	isolated	isolate	B-NP	VBN	O	9	NMOD	0
8	tumor	tumor	I-NP	NN	O	9	NMOD	0
9	ECs	EC	I-NP	NNS	B-cell_type	10	SUB	0
10	have	have	B-VP	VBP	O	6	SBAR	0
11	suppressed	suppress	I-VP	VBN	O	10	VC	18	suppressed
12	levels	level	B-NP	NNS	O	11	OBJ	0
13	of	of	B-PP	IN	O	12	NMOD	0
14	intercellular	intercellular	B-NP	JJ	B-protein	16	NMOD	0
15	adhesion	adhesion	I-NP	NN	I-protein	16	NMOD	0
16	molecule	molecule	I-NP	NN	I-protein	13	PMOD	0
17	1	1	I-NP	CD	I-protein	16	NMOD	0
18	as	as	B-SBAR	IN	O	11	VMOD	0
19	compared	compare	B-PP	VBN	O	18	SBAR	0
20	with	with	B-PP	IN	O	19	VMOD	0
21	ECs	EC	B-NP	NNS	B-cell_type	20	PMOD	0
22	from	from	B-PP	IN	O	21	NMOD	0
23	normal	normal	B-NP	JJ	O	25	NMOD	0
24	mouse	mouse	I-NP	NN	O	25	NMOD	0
25	tissues	tissue	I-NP	NNS	O	22	PMOD	0
26	.	.	O	.	O	5	P	0

1	In	In	B-PP	IN	O	22	VMOD	0
2	cultured	culture	B-NP	VBN	B-cell_line	4	NMOD	0
3	b.END5	b.END5	I-NP	NN	I-cell_line	4	NMOD	0
4	cells	cell	I-NP	NNS	I-cell_line	1	PMOD	0
5	the	the	B-NP	DT	O	10	NMOD	0
6	tumor	tumor	I-NP	NN	B-protein	10	NMOD	0
7	necrosis	necrosis	I-NP	NN	I-protein	10	NMOD	0
8	factor	factor	I-NP	NN	I-protein	10	NMOD	0
9	alpha-induced	alpha-induced	I-NP	JJ	O	10	NMOD	17	induced
10	up-regulation	up-regulation	I-NP	NN	O	22	SUB	17	up-regulation
11	of	of	B-PP	IN	O	10	NMOD	0
12	intercellular	intercellular	B-NP	JJ	B-protein	14	NMOD	0
13	adhesion	adhesion	I-NP	NN	I-protein	14	NMOD	0
14	molecule	molecule	I-NP	NN	I-protein	20	NMOD	0
15	1	1	I-NP	CD	I-protein	14	NMOD	0
16	and	and	O	CC	O	20	NMOD	0
17	vascular	vascular	B-NP	JJ	B-protein	20	NMOD	0
18	cell	cell	I-NP	NN	I-protein	20	NMOD	0
19	adhesion	adhesion	I-NP	NN	I-protein	20	NMOD	0
20	molecule	molecule	I-NP	NN	I-protein	11	PMOD	0
21	1	1	I-NP	CD	I-protein	20	NMOD	0
22	was	be	B-VP	VBD	O	0	ROOT	0
23	reduced	reduce	I-VP	VBN	O	22	VC	18	reduced
24	in	in	B-PP	IN	O	23	VMOD	0
25	ECs	EC	B-NP	NNS	B-cell_type	24	PMOD	0
26	that	that	B-NP	WDT	O	25	NMOD	0
27	were	be	B-VP	VBD	O	26	SBAR	0
28	preincubated	preincubate	I-VP	VBN	O	27	VC	19	preincubated
29	with	with	B-PP	IN	O	28	VMOD	0
30	basic	basic	B-NP	JJ	B-protein	33	NMOD	0
31	fibroblast	fibroblast	I-NP	NN	I-protein	33	NMOD	0
32	growth	growth	I-NP	NN	I-protein	33	NMOD	0
33	factor	factor	I-NP	NN	I-protein	38	NMOD	0
34	or	or	O	CC	O	38	NMOD	0
35	vascular	vascular	B-NP	JJ	B-protein	38	NMOD	0
36	endothelial	endothelial	I-NP	JJ	I-protein	38	NMOD	0
37	growth	growth	I-NP	NN	I-protein	38	NMOD	0
38	factor	factor	I-NP	NN	I-protein	29	PMOD	0
39	.	.	O	.	O	22	P	0

1	The	The	B-NP	DT	O	3	NMOD	0
2	current	current	I-NP	JJ	O	3	NMOD	0
3	results	result	I-NP	NNS	O	4	SUB	0
4	may	may	B-VP	MD	O	0	ROOT	0
5	have	have	I-VP	VB	O	4	VC	0
6	an	an	B-NP	DT	O	7	NMOD	0
7	impact	impact	I-NP	NN	O	5	OBJ	0
8	on	on	B-PP	IN	O	5	VMOD	0
9	the	the	B-NP	DT	O	10	NMOD	0
10	effectiveness	effectiveness	I-NP	NN	O	8	PMOD	0
11	of	of	B-PP	IN	O	10	NMOD	0
12	clinical	clinical	B-NP	JJ	O	13	AMOD	0
13	immunotherapeutic	immunotherapeutic	I-NP	JJ	O	15	NMOD	0
14	treatment	treatment	I-NP	NN	O	15	NMOD	0
15	protocols	protocol	I-NP	NNS	O	11	PMOD	0
16	,	,	O	,	O	4	P	0
17	because	because	B-SBAR	IN	O	4	VMOD	0
18	immune	immune	B-NP	JJ	B-cell_type	20	NMOD	0
19	effector	effector	I-NP	NN	I-cell_type	20	NMOD	0
20	cells	cell	I-NP	NNS	I-cell_type	21	SUB	0
21	may	may	B-VP	MD	O	17	SBAR	0
22	not	not	I-VP	RB	O	21	VMOD	0
23	be	be	I-VP	VB	O	21	VC	0
24	able	able	B-ADJP	JJ	O	23	PRD	0
25	to	to	B-VP	TO	O	26	VMOD	0
26	enter	enter	I-VP	VB	O	24	AMOD	14	enter
27	tumor	tumor	B-NP	NN	O	28	NMOD	0
28	tissue	tissue	I-NP	NN	O	26	OBJ	0
29	.	.	O	.	O	4	P	0

